Key facts
- It has raised $1.0M; the latest was Seed Round ($1.0M) in Oct 2025.
- Notable investors include Brisbane Angels, Sydney Angels.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for iiShield
- ·The full record, as it builds
Funding rounds
No funding rounds for iiShield are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About iiShield
Developer and manufacturer of a kidney protective jacket designed to shield transplanted kidneys from thermal injury during surgery. The company's product is a single-use, cost-effective medical device that aims to increase the available time for kidney transplantation, thereby providing surgeons with a surgical environment that fosters improved short and long-term transplant outcomes.
- Sector
- Healthcare
- HQ
- Sydney, Australia
- Founded
- 2020
- Employees
- 5
- Website
- iishield.com/
- Ownership
- Privately Held (backing)
iiShield doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in iiShield shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on iiShield in its N-PORT filings yet. We sweep new filings monthly.